Ontology highlight
ABSTRACT:
SUBMITTER: Watz H
PROVIDER: S-EPMC7160900 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
Watz Henrik H Hohlfeld Jens M JM Singh Dave D Beier Jutta J Diamant Zuzana Z Liu Jinming J Hua Shucheng S Abd-Elaziz Khalid K Pinot Pascale P Jones Ieuan I Tillmann Hanns-Christian HC
Respiratory research 20200415 1
Indacaterol (IND; 150 μg), glycopyrronium (GLY; 50 μg) and mometasone furoate (MF; 160 μg [high-dose ICS] and 80 μg [medium-dose ICS]) have been formulated as a once-daily (o.d.) fixed-dose combination treatment delivered via the Breezhaler® device for the treatment of patients with asthma. In this randomized (n = 116), double-blind, double-dummy, active comparator-controlled, three-period cross-over study we evaluated the benefit of o.d. IND/GLY/MF versus twice daily (b.i.d.) salmeterol/flutica ...[more]